Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 921

1.

Up-regulation of FOXO1 and reduced inflammation by β-hydroxybutyric acid are essential diet restriction benefits against liver injury.

Miyauchi T, Uchida Y, Kadono K, Hirao H, Kawasoe J, Watanabe T, Ueda S, Okajima H, Terajima H, Uemoto S.

Proc Natl Acad Sci U S A. 2019 Jun 13. pii: 201820282. doi: 10.1073/pnas.1820282116. [Epub ahead of print]

2.

Outcomes of liver transplantation for Alagille syndrome after Kasai portoenterostomy: Alagille Syndrome with agenesis of extrahepatic bile ducts at porta hepatis.

Gunadi, Kaneshiro M, Okamoto T, Sonoda M, Ogawa E, Okajima H, Uemoto S.

J Pediatr Surg. 2019 May 6. pii: S0022-3468(19)30323-9. doi: 10.1016/j.jpedsurg.2019.04.022. [Epub ahead of print]

PMID:
31104835
3.

A Minimal Physiologically-Based Pharmacokinetic Model for Tacrolimus in Living-Donor Liver Transplantation: Perspectives Related to Liver Regeneration and the cytochrome P450 3A5 (CYP3A5) Genotype.

Itohara K, Yano I, Tsuzuki T, Uesugi M, Nakagawa S, Yonezawa A, Okajima H, Kaido T, Uemoto S, Matsubara K.

CPT Pharmacometrics Syst Pharmacol. 2019 May 14. doi: 10.1002/psp4.12420. [Epub ahead of print]

4.

Liver Transplantation in Japan: Registry by the Japanese Liver Transplantation Society.

Umeshita K, Eguchi S, Egawa H, Haga H, Kasahara M, Kokudo N, Sakisaka S, Takada Y, Tanaka E, Eguchi H, Uemoto S, Ohdan H; Japanese Liver Transplantation Society.

Hepatol Res. 2019 May 13. doi: 10.1111/hepr.13364. [Epub ahead of print]

PMID:
31081572
5.

Surgery for Recurrent Hepatocellular Carcinoma: Achieving Long-term Survival.

Yoh T, Seo S, Taura K, Iguchi K, Ogiso S, Fukumitsu K, Ishii T, Kaido T, Uemoto S.

Ann Surg. 2019 Apr 30. doi: 10.1097/SLA.0000000000003358. [Epub ahead of print]

PMID:
31058698
6.

Bolus Administration of Polyamines Boosts Effects on Hepatic Ischemia-Reperfusion Injury and Regeneration in Rats.

Doi J, Fujimoto Y, Teratani T, Kasahara N, Maeda M, Tsuruyama T, Iida T, Yagi S, Uemoto S.

Eur Surg Res. 2019 May 3;60(1-2):63-73. doi: 10.1159/000497434. [Epub ahead of print]

PMID:
31055575
7.

The Impact of a Nitric Oxide Synthase Inhibitor (L-NAME) on Ischemia⁻Reperfusion Injury of Cholestatic Livers by Pringle Maneuver and Liver Resection after Bile Duct Ligation in Rats.

Iwasaki J, Afify M, Bleilevens C, Klinge U, Weiskirchen R, Steitz J, Vogt M, Yagi S, Nagai K, Uemoto S, Tolba RH.

Int J Mol Sci. 2019 Apr 29;20(9). pii: E2114. doi: 10.3390/ijms20092114.

8.

Novel hybrid three-dimensional artificial liver using human induced pluripotent stem cells and a rat decellularized liver scaffold.

Minami T, Ishii T, Yasuchika K, Fukumitsu K, Ogiso S, Miyauchi Y, Kojima H, Kawai T, Yamaoka R, Oshima Y, Kawamoto H, Kotaka M, Yasuda K, Osafune K, Uemoto S.

Regen Ther. 2019 Mar 30;10:127-133. doi: 10.1016/j.reth.2019.03.002. eCollection 2019 Jun.

9.

Laparoscopic approach for choledochojejunostomy.

Hori T, Aisu Y, Yamamoto M, Yasukawa D, Iida T, Yagi S, Taniguchi K, Uemoto S.

Hepatobiliary Pancreat Dis Int. 2019 Jun;18(3):285-288. doi: 10.1016/j.hbpd.2019.04.004. Epub 2019 Apr 17. No abstract available.

PMID:
31023579
10.

Preoperative Visceral Adiposity and Muscularity Predict Poor Outcomes after Hepatectomy for Hepatocellular Carcinoma.

Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, Yao S, Yagi S, Kamo N, Seo S, Taura K, Okajima H, Uemoto S.

Liver Cancer. 2019 Mar;8(2):92-109. doi: 10.1159/000488779. Epub 2018 Jun 5.

11.

The Efficacy and Limitations of Postoperative Adjuvant Chemotherapy in Patients With Extrahepatic Cholangiocarcinoma.

Morino K, Seo S, Yoh T, Nishino H, Yamanaka K, Fukumitsu K, Ishii T, Taura K, Okajima H, Kaido T, Uemoto S.

Anticancer Res. 2019 Apr;39(4):2155-2161. doi: 10.21873/anticanres.13329.

PMID:
30952762
12.

Laparoscopic Left Lateral Sectionectomy Using the Extrahepatic Glissonean Approach: A Secure Option for Achieving a Negative Margin for Lesions with Ductal Extension.

Ogiso S, Seo S, Okumura S, Ishii T, Fukumitsu K, Ito T, Masui T, Taura K, Kaido T, Uemoto S.

Ann Surg Oncol. 2019 Jun;26(6):1858. doi: 10.1245/s10434-019-07298-8. Epub 2019 Mar 18.

PMID:
30887372
13.

Significance of preoperative sarcopenia to liver surgery.

Kaido T, Hamaguchi Y, Uemoto S.

Hepatobiliary Surg Nutr. 2019 Feb;8(1):59-62. doi: 10.21037/hbsn.2018.11.05. No abstract available.

14.

Predictive value of the Ki67 index for lymph node metastasis of small non-functioning pancreatic neuroendocrine neoplasms.

Masui T, Sato A, Nakano K, Uchida Y, Yogo A, Anazawa T, Nagai K, Kawaguchi Y, Takaori K, Uemoto S.

Surg Today. 2019 Mar 5. doi: 10.1007/s00595-019-01779-9. [Epub ahead of print]

PMID:
30838442
15.

Impact of imbalanced graft-to-spleen volume ratio on outcomes following living donor liver transplantation in an era when simultaneous splenectomy is not typically indicated.

Yao S, Kaido T, Yagi S, Uozumi R, Iwamura S, Miyachi Y, Shirai H, Kamo N, Taura K, Okajima H, Uemoto S.

Am J Transplant. 2019 Mar 4. doi: 10.1111/ajt.15337. [Epub ahead of print]

PMID:
30830721
16.

Clinical Practice of Postoperative Adjuvant Chemotherapy in Patients with Colorectal Liver Metastases: Impact of the Completion for Six Months.

Nishino H, Hatano E, Okuno M, Toda R, Seo S, Taura K, Horimatsu T, Kanai M, Hasegawa S, Matsumoto S, Sakai Y, Uemoto S.

Am Surg. 2019 Feb 1;85(2):e111-e114. No abstract available.

PMID:
30819321
17.

Efficacy and safety of glecaprevir and pibrentasvir treatment for 8 or 12 weeks in patients with recurrent hepatitis C after liver transplantation: a Japanese multicenter experience.

Ueda Y, Kobayashi T, Ikegami T, Miuma S, Mizuno S, Akamatsu N, Takaki A, Ishigami M, Takatsuki M, Sugawara Y, Maehara Y, Uemoto S, Seno H.

J Gastroenterol. 2019 Feb 26. doi: 10.1007/s00535-019-01561-1. [Epub ahead of print]

PMID:
30806783
18.

Comprehensive analysis of genetic aberrations linked to tumorigenesis in regenerative nodules of liver cirrhosis.

Kim SK, Takeda H, Takai A, Matsumoto T, Kakiuchi N, Yokoyama A, Yoshida K, Kaido T, Uemoto S, Minamiguchi S, Haga H, Shiraishi Y, Miyano S, Seno H, Ogawa S, Marusawa H.

J Gastroenterol. 2019 Feb 12. doi: 10.1007/s00535-019-01555-z. [Epub ahead of print]

PMID:
30756187
19.

Reply - Letter to the Editor - Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation.

Kaido T, Kamo N, Uemoto S.

Clin Nutr. 2019 Apr;38(2):967. doi: 10.1016/j.clnu.2019.01.024. Epub 2019 Feb 1. No abstract available.

PMID:
30739810
20.

Exocrine tissue-driven TFF2 prevents apoptotic cell death of endocrine lineage during pancreas organogenesis.

Hirata K, Kodama S, Nakano Y, Minaki-Nakagawa Y, Aoyama Y, Sakikubo M, Goto T, Yoshida M, Masui T, Yamamoto T, Uemoto S, Kawaguchi Y.

Sci Rep. 2019 Feb 7;9(1):1636. doi: 10.1038/s41598-018-38062-9.

21.

Clinical and experimental studies of intraperitoneal lipolysis and the development of clinically relevant pancreatic fistula after pancreatic surgery.

Uchida Y, Masui T, Nakano K, Yogo A, Sato A, Nagai K, Anazawa T, Takaori K, Tabata Y, Uemoto S.

Br J Surg. 2019 Apr;106(5):616-625. doi: 10.1002/bjs.11075. Epub 2019 Feb 6.

PMID:
30725479
22.

Early post-operative intravenous tacrolimus in pediatric liver transplant recipients is not superior to oral tacrolimus.

Sabra TA, Okajima H, Yoshizawa A, Ogawa E, Okamoto S, Osman MA, Saad-Eldin Y, Uemoto S.

Pediatr Transplant. 2019 Feb 4:e13368. doi: 10.1111/petr.13368. [Epub ahead of print]

PMID:
30719833
23.

Risk-benefit point of the Model for End-stage Liver Disease score in patients waiting for deceased-donor liver transplantation: A single-center experience.

Iwamura S, Kaido T, Morita S, Miyachi Y, Yao S, Shirai H, Kobayashi A, Hamaguchi Y, Kamo N, Yagi S, Uemoto S.

Hepatol Res. 2019 Jan 30. doi: 10.1111/hepr.13320. [Epub ahead of print]

PMID:
30698359
24.

Current state and future evolution of pancreatic islet transplantation.

Anazawa T, Okajima H, Masui T, Uemoto S.

Ann Gastroenterol Surg. 2018 Oct 8;3(1):34-42. doi: 10.1002/ags3.12214. eCollection 2019 Jan. Review.

25.

Reappraisal of Prognostic Impact of Tumor SUVmax by 18F-FDG-PET/CT in Intrahepatic Cholangiocarcinoma.

Yoh T, Seo S, Morino K, Fuji H, Ikeno Y, Ishii T, Taura K, Nakamoto Y, Higashi T, Kaido T, Uemoto S.

World J Surg. 2019 May;43(5):1323-1331. doi: 10.1007/s00268-019-04917-z.

PMID:
30680501
26.

Low Titers of Antidonor ABO Antibodies After ABO-Incompatible Living Donor Liver Transplantation: A Long-Term Follow-Up Study.

Ueda D, Yoshizawa A, Kaneshiro M, Hirata Y, Yagi S, Hata K, Okajima H, Egawa H, Uemoto S.

Transplant Direct. 2018 Dec 27;5(1):e420. doi: 10.1097/TXD.0000000000000858. eCollection 2019 Jan.

27.

POGLUT1, the putative effector gene driven by rs2293370 in primary biliary cholangitis susceptibility locus chromosome 3q13.33.

Hitomi Y, Ueno K, Kawai Y, Nishida N, Kojima K, Kawashima M, Aiba Y, Nakamura H, Kouno H, Kouno H, Ohta H, Sugi K, Nikami T, Yamashita T, Katsushima S, Komeda T, Ario K, Naganuma A, Shimada M, Hirashima N, Yoshizawa K, Makita F, Furuta K, Kikuchi M, Naeshiro N, Takahashi H, Mano Y, Yamashita H, Matsushita K, Tsunematsu S, Yabuuchi I, Nishimura H, Shimada Y, Yamauchi K, Komatsu T, Sugimoto R, Sakai H, Mita E, Koda M, Nakamura Y, Kamitsukasa H, Sato T, Nakamuta M, Masaki N, Takikawa H, Tanaka A, Ohira H, Zeniya M, Abe M, Kaneko S, Honda M, Arai K, Arinaga-Hino T, Hashimoto E, Taniai M, Umemura T, Joshita S, Nakao K, Ichikawa T, Shibata H, Takaki A, Yamagiwa S, Seike M, Sakisaka S, Takeyama Y, Harada M, Senju M, Yokosuka O, Kanda T, Ueno Y, Ebinuma H, Himoto T, Murata K, Shimoda S, Nagaoka S, Abiru S, Komori A, Migita K, Ito M, Yatsuhashi H, Maehara Y, Uemoto S, Kokudo N, Nagasaki M, Tokunaga K, Nakamura M.

Sci Rep. 2019 Jan 14;9(1):102. doi: 10.1038/s41598-018-36490-1.

28.

Bone mineral density correlates with survival after resection of extrahepatic biliary malignancies.

Yao S, Kaido T, Okumura S, Iwamura S, Miyachi Y, Shirai H, Kobayashi A, Hamaguchi Y, Kamo N, Uozumi R, Yagi S, Uemoto S.

Clin Nutr. 2018 Dec 17. pii: S0261-5614(18)32570-6. doi: 10.1016/j.clnu.2018.12.004. [Epub ahead of print]

PMID:
30595376
29.

The Relationship Between 18F-FDG Uptake on PET/CT and Markers of Systemic Inflammatory Response in Patients Undergoing Surgery for Intrahepatic Cholangiocarcinoma.

Seo S, Yoh T, Morino K, Fuji H, Taura K, Fukumitsu K, Ishii T, Nakamoto Y, Kaido T, Uemoto S.

Anticancer Res. 2019 Jan;39(1):341-346. doi: 10.21873/anticanres.13117.

PMID:
30591478
30.

Expansion of viral variants associated with immune escape and impaired virion secretion in patients with HBV reactivation after resolved infection.

Inuzuka T, Ueda Y, Arasawa S, Takeda H, Matsumoto T, Osaki Y, Uemoto S, Seno H, Marusawa H.

Sci Rep. 2018 Dec 24;8(1):18070. doi: 10.1038/s41598-018-36093-w.

31.

Correction: Hammad, A.; Kaido, T.; Aliyev V.; Mandato C.; Uemoto S. Nutritional Therapy in Liver Transplantation. Nutrients 2017; 9. E1126.

Hammad A, Kaido T, Aliyev V, Mandato C, Uemoto S.

Nutrients. 2018 Dec 18;10(12). pii: E2006. doi: 10.3390/nu10122006.

32.

Impact of pretreatments on outcomes after living donor liver transplantation for hepatocellular carcinoma.

Ogawa K, Kaido T, Okajima H, Fujimoto Y, Yoshizawa A, Yagi S, Hori T, Iida T, Takada Y, Uemoto S.

J Hepatobiliary Pancreat Sci. 2019 Feb;26(2):73-81. doi: 10.1002/jhbp.602. Epub 2019 Jan 21.

PMID:
30561147
33.

Expanded living-donor liver transplantation criteria for patients with hepatocellular carcinoma based on the Japanese nationwide survey: the 5-5-500 rule - a retrospective study.

Shimamura T, Akamatsu N, Fujiyoshi M, Kawaguchi A, Morita S, Kawasaki S, Uemoto S, Kokudo N, Hasegawa K, Ohdan H, Egawa H, Furukawa H, Todo S; Japanese Liver Transplantation Society.

Transpl Int. 2019 Apr;32(4):356-368. doi: 10.1111/tri.13391. Epub 2019 Jan 18.

PMID:
30556935
34.

Henoch-Schönlein Purpura After Living Donor Liver Transplantation: Report of the First Case.

Aliyev V, Yagi S, Hammad A, Badawy A, Taura K, Okajima H, Takaori K, Kaido T, Uemoto S.

Transplant Proc. 2018 Dec;50(10):4050-4052. doi: 10.1016/j.transproceed.2018.02.072. Epub 2018 Mar 9.

PMID:
30522857
35.

Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation.

Kamo N, Kaido T, Hamaguchi Y, Okumura S, Kobayashi A, Shirai H, Yao S, Yagi S, Uemoto S.

Clin Nutr. 2018 Sep 28. pii: S0261-5614(18)32457-9. doi: 10.1016/j.clnu.2018.09.019. [Epub ahead of print]

PMID:
30482562
36.

Efficiency of acoustic radiation force impulse imaging for the staging of graft fibrosis after liver transplantation.

Yoshino K, Taura K, Okuda Y, Ikeno Y, Uemoto Y, Nishio T, Yamamoto G, Tanabe K, Koyama Y, Seo S, Kaido T, Okajima H, Imai T, Tanaka S, Uemoto S.

Hepatol Res. 2019 Apr;49(4):394-403. doi: 10.1111/hepr.13289. Epub 2019 Jan 2.

PMID:
30471140
37.

Bone Mineral Density as a Risk Factor for Patients Undergoing Surgery for Hepatocellular Carcinoma.

Miyachi Y, Kaido T, Yao S, Shirai H, Kobayashi A, Hamaguchi Y, Kamo N, Yagi S, Uemoto S.

World J Surg. 2019 Mar;43(3):920-928. doi: 10.1007/s00268-018-4861-x.

PMID:
30465085
38.

Human Atrial Natriuretic Peptide in Cold Storage of Donation After Circulatory Death Rat Livers: An Old but New Agent for Protecting Vascular Endothelia?

Nigmet Y, Hata K, Tamaki I, Okamura Y, Tsuruyama T, Miyauchi H, Kusakabe J, Tajima T, Hirao H, Kubota T, Inamoto O, Yoshikawa J, Goto T, Tanaka H, Uemoto S.

Transplantation. 2019 Mar;103(3):512-521. doi: 10.1097/TP.0000000000002552.

PMID:
30461725
39.

Current Status of Liver Transplantation Using Marginal Grafts.

Badawy A, Kaido T, Uemoto S.

J Invest Surg. 2018 Nov 20:1-12. doi: 10.1080/08941939.2018.1517197. [Epub ahead of print]

PMID:
30457408
40.

Reply to: "Relationship Between Sarcopenic Obesity and Outcomes of Hepatectomy for Hepatocellular Carcinoma".

Kaido T, Kobayashi A, Hamaguchi Y, Yao S, Uemoto S.

Ann Surg. 2018 Dec;268(6):e87. doi: 10.1097/SLA.0000000000002788. No abstract available.

PMID:
30423791
41.

Ptf1a inactivation in adult pancreatic acinar cells causes apoptosis through activation of the endoplasmic reticulum stress pathway.

Sakikubo M, Furuyama K, Horiguchi M, Hosokawa S, Aoyama Y, Tsuboi K, Goto T, Hirata K, Masui T, Dor Y, Fujiyama T, Hoshino M, Uemoto S, Kawaguchi Y.

Sci Rep. 2018 Oct 25;8(1):15812. doi: 10.1038/s41598-018-34093-4.

42.

Serum Nardilysin, a Surrogate Marker for Epithelial-Mesenchymal Transition, Predicts Prognosis of Intrahepatic Cholangiocarcinoma after Surgical Resection.

Yoh T, Hatano E, Kasai Y, Fuji H, Nishi K, Toriguchi K, Sueoka H, Ohno M, Seo S, Iwaisako K, Taura K, Yamaguchi R, Kurokawa M, Fujimoto J, Kimura T, Uemoto S, Nishi E.

Clin Cancer Res. 2019 Jan 15;25(2):619-628. doi: 10.1158/1078-0432.CCR-18-0124. Epub 2018 Oct 23.

PMID:
30352908
43.

ASO Author Reflections: Recurrence Type of NEN Around the Head of the Pancreas.

Masui T, Uemoto S.

Ann Surg Oncol. 2018 Dec;25(Suppl 3):812-813. doi: 10.1245/s10434-018-6875-x. Epub 2018 Oct 12. No abstract available.

PMID:
30315383
44.

Conceptual framework of middle hepatic vein anatomy as a roadmap for safe right hepatectomy.

Ogiso S, Okuno M, Shindoh J, Sakamoto Y, Mizuno T, Araki K, Goumard C, Nomi T, Ishii T, Uemoto S, Chun YS, Tzeng CD, Lee JE, Vauthey JN, Conrad C.

HPB (Oxford). 2019 Jan;21(1):43-50. doi: 10.1016/j.hpb.2018.01.002. Epub 2018 Sep 25.

PMID:
30266496
45.

Effect of mapping biopsy on surgical management of cholangiocarcinoma.

Yao S, Taura K, Okuda Y, Kodama Y, Uza N, Gouda N, Minamiguchi S, Okajima H, Kaido T, Uemoto S.

J Surg Oncol. 2018 Nov;118(6):997-1005. doi: 10.1002/jso.25226. Epub 2018 Sep 9.

PMID:
30196565
46.

CD90 expression in human intrahepatic cholangiocarcinoma is associated with lymph node metastasis and poor prognosis.

Yamaoka R, Ishii T, Kawai T, Yasuchika K, Miyauchi Y, Kojima H, Katayama H, Ogiso S, Fukumitsu K, Uemoto S.

J Surg Oncol. 2018 Sep;118(4):664-674. doi: 10.1002/jso.25192. Epub 2018 Sep 9.

PMID:
30196535
47.

Optimal introduction of laparoscopic liver resection for Child-Pugh B.

Fuji H, Seo S, Toda R, Yoh T, Ikeno Y, Fukumitsu K, Ishii T, Taura K, Hatano E, Kaido T, Uemoto S.

Asian J Endosc Surg. 2018 Aug 21. doi: 10.1111/ases.12634. [Epub ahead of print]

PMID:
30133178
48.

Hydrogen Flush After Cold Storage as a New End-Ischemic Ex Vivo Treatment for Liver Grafts Against Ischemia/Reperfusion Injury.

Tamaki I, Hata K, Okamura Y, Nigmet Y, Hirao H, Kubota T, Inamoto O, Kusakabe J, Goto T, Tajima T, Yoshikawa J, Tanaka H, Tsuruyama T, Tolba RH, Uemoto S.

Liver Transpl. 2018 Nov;24(11):1589-1602. doi: 10.1002/lt.25326.

PMID:
30120877
49.

Cracking pattern of tissue slices induced by external extension provides useful diagnostic information.

Danno K, Nakamura T, Okoso N, Nakamura N, Iguchi K, Iwadate Y, Kenmotsu T, Ikegawa M, Uemoto S, Yoshikawa K.

Sci Rep. 2018 Aug 15;8(1):12167. doi: 10.1038/s41598-018-30662-9.

50.

[Pancreatic islet transplantation:current status and future perspectives].

Anazawa T, Okajima H, Uemoto S.

Nihon Shokakibyo Gakkai Zasshi. 2018;115(8):700-705. doi: 10.11405/nisshoshi.115.700. Japanese. No abstract available.

PMID:
30101870

Supplemental Content

Loading ...
Support Center